HR0716LRB101 20252 MST 69792 r

1
HOUSE RESOLUTION

 
2    WHEREAS, Cholangiocarcinoma (bile duct cancer) is a rare
3form of cancer that originates from the cells lining the bile
4ducts that play a key role in digestion; there are three types,
5Intrahepatic, extrahepatic, and perihilar; and
 
6    WHEREAS, There are approximately 12,000 Americans
7diagnosed each year in the United States, with numbers
8increasing yearly; the mortality rate has increased
9dramatically in the last decade; and
 
10    WHEREAS, Patients are typically diagnosed at a late stage
11due to no validated early method of detection; symptoms of
12jaundice, abdominal pain, itchy skin, and weight loss are
13symptoms that do not usually present till advanced disease
14progression; and
 
15    WHEREAS, Cholangiocarcinoma is a rare cancer; of the top
16eight deadliest cancers, seven are rare; rare cancers have a
17five-year survival rate under 50%, with the cholangiocarcinoma
18five-year survival rate being approximately 20%; and
 
19    WHEREAS, There is currently no cure for
20cholangiocarcinoma/bile duct cancer; and
 

 

 

HR0716- 2 -LRB101 20252 MST 69792 r

1    WHEREAS, Kelly green is the color representing
2cholangiocarcinoma/bile duct cancer awareness; and
 
3    WHEREAS, Foundations, research and teaching hospitals,
4rare cancer advocate groups, and patient advocate groups from
5around the globe have joined together to recognize February 12,
62020 as World Cholangiocarcinoma Day; and
 
7    WHEREAS, Increased cholangiocarcinoma advocacy, awareness,
8research, and education will bring improved outcomes for
9patients in earlier detection and treatment and potential
10curative methods; therefore, be it
 
11    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE
12HUNDRED FIRST GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that
13we recognize February 12, 2020 as being World
14Cholangiocarcinoma Day.